X
Xiao-Dong Zhu
Researcher at Fudan University
Publications - 166
Citations - 5158
Xiao-Dong Zhu is an academic researcher from Fudan University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 27, co-authored 129 publications receiving 3734 citations. Previous affiliations of Xiao-Dong Zhu include Fudan University Shanghai Medical College & Chinese Ministry of Education.
Papers
More filters
Journal Article
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition.
Xin-Yu Zhang,Xin-Yu Zhang,Ping-Ting Gao,Ping-Ting Gao,Xuan Yang,Xuan Yang,Jia-Bin Cai,Jia-Bin Cai,Guang-Yu Ding,Guang-Yu Ding,Xiao-Dong Zhu,Xiao-Dong Zhu,Yuan Ji,Guo-Ming Shi,Guo-Ming Shi,Ying-Hao Shen,Ying-Hao Shen,Jian Zhou,Jian Zhou,Jia Fan,Jia Fan,Hui-Chuan Sun,Hui-Chuan Sun,Liu-Xiao Yang,Cheng Huang,Cheng Huang +25 more
TL;DR: SBP1 was significantly downregulated in ICC tumor tissues, especially in tumor tissues from ICC patients with recurrence or tumor vascular invasion, compared with that in peritumoral tissues, and was an independent prognostic factor in ICC.
Journal ArticleDOI
Adjuvant apatinib treatment after resection of hepatocellular carcinoma with portal vein tumor thrombosis: a phase II trial
Hui-Chuan Sun,Xiao-Dong Zhu,Jian Zhou,Qiang Gao,Ying-Hong Shi,Zhen-Bing Ding,Cheng Huang,Shuang-Jian Qiu,Ning Ren,Guo-Ming Shi,Jian Sun,Qing-Hai Ye,Xiao-Wu Huang,Xin-Rong Yang,Jia Fan +14 more
TL;DR: Apatinib was well tolerated in patients after resection of HCC with PVTT, and the median RFS in this group was improved compared with that previously reported.
Journal ArticleDOI
Clinical applications of extracellular vesicle long RNAs
TL;DR: It is shown that EVs have higher stability, greater difference in temporal and spatial expression, and the capacity to remodel both proximal and distal recipient cells, hence providing insights for future studies.
Journal ArticleDOI
Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis
TL;DR: The α- Fetoprotein response is a reliable and simple predictive marker for evaluating the oncological effect of surgical resection for hepatocellular carcinoma with positive α-fetoprotein before resection, independent of tumor features.
Journal ArticleDOI
CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression.
Min-Cheng Yu,Guang-Yu Ding,Peng Ma,Yue-Da Chen,Xiao-Dong Zhu,Jia-Bin Cai,Ying-Hao Shen,Jian Zhou,Jia Fan,Hui-Chuan Sun,Ming Kuang,Cheng Huang +11 more
TL;DR: The findings suggest that circUBAP2 promotes HCC growth and metastasis and may have value as an independent prognostic biomarker or as a new target for the treatment of HCC.